NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-024-2009-0-FR-12 GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS FR EP 13188475.1 Issued
NIDDK E-743-2013-0-US-01 THERAPEUTIC POLYPEPTIDES AND THEIR USE US 61/890,585 Abandoned
NCI E-181-2009-4-US-06 Peptide Mimetic Ligands Of Polo-like Kinase 1 Polo Box Domain and Methods of Use US National Stage 14/111,540 10266565 Issued PDF
NINDS E-251-2005-2-JP-07 Improvements To Vibro-tactile Stimulation Device JP DIV 2013-213610 Issued
NCI E-068-2011-0-US-03 Human Monoclonal Antibodies That Bind Insulin-Like Growth Factor (IGF) I And II US ORD 14/111,507 9150644 Issued PDF
NCI E-181-2009-4-JP-05 Peptide Mimetic Ligands of Polo-like Kinase1 Polo Box Domain and Method of Use JP National Stage 2014-505275 Abandoned
NHLBI E-241-2010-0-KR-12 Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery KR National Stage 10-2013-7026982 Abandoned
NIAID E-531-2013-0-US-01 NOVEL EPSTEIN-BARR VIRUS VACCINES US 61/889,840 Abandoned
NCI E-344-2013-0-US-01 TEM8 ANTIBODIES AND THEIR USE US 61/889,958 Abandoned
NCATS E-757-2013-0-US-01 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives As Potent And Selective Inhibitors Of Human 12-Lipoxygenase. US 61/889,396 Abandoned
NIDCR E-736-2013-0-US-01 Detection of Hepatitis Delta Virus and Use Thereof For The Diagnosis and Treatment of Sojgren's Syndrome US 61/888,706 Abandoned
NHLBI E-261-2012-0-US-02 Imaging Methods and Computer-Readable Media US ORD 14/049,096 9449377 Abandoned PDF
NEI E-075-2011-0-US-06 Methods of Diagnosing and Treating Age-Related Macular Degeneration US National Stage 13/981,368 Abandoned
NICHD E-157-2011-0-US-04 Small Molecule Therapeutic Compounds Targeting Thioesterase Deficiency Disorders And Methods Of Using The Same US National Stage 14/110,393 9629816 Issued PDF
NCATS E-217-2013-0-PCT-02 A NEW CHEMICAL ENTITY USEFUL FOR TREATING VARIOUS DISEASES PCT PCT PCT/US2013/063616 Expired
NCI E-771-2013-0-US-01 Modified Pseudomonas Exotoxin A US 61/887,418 Abandoned
NIAID E-089-2012-0-PCT-02 A Formulation Of Mycobacterial Components As An Adjuvant For Inducing TH17 Response PCT PCT PCT/US2013/063388 Expired
NCI E-148-2011-0-JP-08 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer JP National Stage 2014-503673 Issued
NCI E-141-2008-0-NZ-13 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof NZ DIV 616254 Issued
NCI E-148-2011-0-IL-07 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer IL National Stage 228686 Issued
NHGRI E-242-2012-0-PCT-02 RECURRENT MUTATION IN MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5 (MAP3K5) FOR DIAGNOSING AND TREATING MELANOMA PCT PCT PCT/US2013/063077 Expired
NINDS E-023-2014-0-US-01 Insulin-Like Growth Factor Mimetics For Use In Therapy US 61/885,811 Abandoned
NCI E-003-2007-0-US-15 Engineered Antibody Constant Domain Molecules US DIV 14/043,366 9527903 Issued PDF
NIDCR E-619-2013-0-US-01 METHODS OF MODULATING ERYTHROPOIESIS WITH ARGININE VASOPRESSIN RECEPTOR 1B MOLECULES US 61/885,258 Abandoned
NHLBI E-342-2013-0-US-01 Human IPSC-derived Vascular-related And Hematopoetic Cells For Therapies And Toxicology/drug Screenings US 61/885,209 Abandoned
CC E-013-2013-0-EP-05 MULTI-FOCI SONICATIONS FOR HYPERTHERMIA TREATMENTS USING MAGNETIC RESONANCE-GUIDED FOCUSSED ULTRASOUND EP National Stage 13814610.5 Issued
CC E-013-2013-0-JP-09 MULTI-FOCI SONICATIONS FOR HYPERTHERMIA TREATMENTS USING MAGNETIC RESONANCE-GUIDED FOCUSSED ULTRASOUND JP National Stage 2015-536248 Issued
CC E-013-2013-0-PCT-02 MULTI-FOCI SONICATIONS FOR HYPERTHERMIA TREATMENTS USING MAGNETIC RESONANCE-GUIDED FOCUSSED ULTRASOUND. PCT PCT PCT/IB2013/059001 Expired
CC E-013-2013-0-IN-06 MULTI FOCI SONICATIONS FOR HYPERTHERMIA TREATMENTS USING MAGNETIC RESONANCE GUIDED FOCUSSED ULTRASOUND IN National Stage 2632/CHENP/2015 Abandoned
NINDS E-113-2011-0-CA-04 WIRELESSLY POWERED MRI SIGNAL AMPLIFICATION SYSTEM AND METHOD CA National Stage 2831793 Issued
NCI E-768-2013-0-US-01 Hyperpolarized Media Transport Vessel US ORD 14/038,948 9874622 Issued PDF
NINDS E-113-2011-0-US-06 Wirelessly Powered MRI Signal Amplification System and Method US National Stage 14/008,133 9864026 Issued PDF
NCI E-766-2013-0-US-01 INTERFERON COMPOSITIONS AND USES THEREOF US 61/883,699 Abandoned
NHLBI E-214-2012-0-PCT-02 TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) INJURY PCT PCT PCT/US2013/061693 Expired
NIDCR E-232-2011-1-PCT-02 METHODS FOR THE DIAGNOSIS AND TREATMENT OF SJOGRENS SYNDROME PCT PCT PCT/US2013/061587 Expired
NHLBI E-214-2012-0-EP-05 Compositions and Methods for the Treatment of Central Nervous System (CNS) Injury EP National Stage 13771750.0 Abandoned
NHLBI E-006-2014-0-US-01 MRI Compatible 3-D Inracardiac Echography Catheter And System US 61/882,371 Abandoned
NIAID E-530-2013-0-US-01 DESMOLARIS COMPOSITIONS AND METHODS OF USE US 61/882,340 Abandoned
NHLBI E-214-2012-0-AU-03 Compositions and Methods for the Treatment of Central Nervous System (CNS) Injury AU National Stage 2013323679 Abandoned
NIA E-084-2011-0-US-04 COMPOSITIONS FOR ENHANCING THE PLURIPOTENCY OF STEM CELLS US National Stage 14/006,954 11059869 Issued PDF
NHLBI E-145-2010-2-CA-02 Methods And Compositions For Modulating BCL-2 Family Polypeptides CA National Stage 2700925 Issued
NCI E-106-2006-3-DE-09 T Cell Receptors And Related Materials And Methods Of Use DE EP 13185475.4 Abandoned
NCI E-106-2006-3-FR-10 T Cell Receptors And Related Materials And Methods Of Use FR EP 13185475.4 Abandoned
NCI E-106-2006-3-GB-11 T Cell Receptors And Related Materials And Methods Of Use GB EP 13185475.4 Abandoned
NICHD E-120-2015-0-NZ-17 Method For On-demand Contraception NZ DIV 615430 Issued
NIA E-084-2011-0-JP-07 Compositions and Methods for Enhancing the Pluripotency of Stem Cells JP National Stage 2014-501218 Issued
NIAID E-123-2007-0-US-08 Monoclonal Antibodies That Neutralize Anthrax Toxin US DIV 14/031,508 8961975 Abandoned PDF
NCI E-191-2009-0-US-08 AKT PHOSPHORYLATION AT SER473 AS AN INDICATOR FOR TAXANE-BASED CHEMOTHERAPY US DIV 14/031,699 Abandoned
NINDS E-547-2013-0-US-01 COMPOSITIONS AND METHODS FOR INHIBITING JC VIRUS (JCV) US 61/879,833 Abandoned
NHLBI E-089-2013-0-US-01 CHEMICALLY DEFINED CULTURE MEDIUM FOR STEM CELL MAINTENANCE AND DIFFERENTIATION US 61/879,840 Abandoned